Literature DB >> 19556128

Tetrahydrocarbazole amides with potent activity against human papillomaviruses.

Kristjan S Gudmundsson1, Sharon D Boggs, Paul R Sebahar, Leah D'Aurora Richardson, Andrew Spaltenstein, Pamela Golden, Phiroze B Sethna, Kevin W Brown, Kelly Moniri, Robert Harvey, Karen R Romines.   

Abstract

Synthesis of a series of tetrahydrocarbazole amides with potent activity against human papillomaviruses is described. Synthetic approaches allowing for variation of the substitution pattern of the tetrahydrocarbazole and the amide are outlined and resulting changes in antiviral activity and certain developability parameters are highlighted. Several compounds with in vitro antiviral activity (W12 antiviral assay) in the single digit nanomolar range were identified and N-[(1R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl]-2-pyridinecarboxamide was selected for further evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556128     DOI: 10.1016/j.bmcl.2009.06.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.

Authors:  Priya Luthra; Jacinth Naidoo; Colette A Pietzsch; Sampriti De; Sudip Khadka; Manu Anantpadma; Caroline G Williams; Megan R Edwards; Robert A Davey; Alexander Bukreyev; Joseph M Ready; Christopher F Basler
Journal:  Antiviral Res       Date:  2018-08-23       Impact factor: 5.970

2.  Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.

Authors:  Richard M Deans; David W Morgens; Ayşe Ökesli; Sirika Pillay; Max A Horlbeck; Martin Kampmann; Luke A Gilbert; Amy Li; Roberto Mateo; Mark Smith; Jeffrey S Glenn; Jan E Carette; Chaitan Khosla; Michael C Bassik
Journal:  Nat Chem Biol       Date:  2016-03-28       Impact factor: 15.040

3.  Tetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activity.

Authors:  Maike Bublitz; Lasse Kjellerup; Karen O'Hanlon Cohrt; Sandra Gordon; Anne Louise Mortensen; Johannes D Clausen; Thomas David Pallin; John Bondo Hansen; Anja Thoe Fuglsang; William Dalby-Brown; Anne-Marie L Winther
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 4.  More Than Resveratrol: New Insights into Stilbene-Based Compounds.

Authors:  Paulina Pecyna; Joanna Wargula; Marek Murias; Malgorzata Kucinska
Journal:  Biomolecules       Date:  2020-07-27

5.  Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma.

Authors:  Yajie Yu; Jane Ding; Shunqin Zhu; Ahmet Alptekin; Zheng Dong; Chunhong Yan; Yunhong Zha; Han-Fei Ding
Journal:  Cell Death Dis       Date:  2021-08-30       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.